UnitedHealth Group Inc (NYSE:UNH) – Research analysts at Oppenheimer lifted their FY2019 earnings per share (EPS) estimates for UnitedHealth Group in a research note issued on Wednesday. Oppenheimer analyst M. Wiederhorn now expects that the healthcare conglomerate will post earnings of $13.38 per share for the year, up from their previous forecast of $12.33. Oppenheimer has a “Outperform” rating and a $240.00 price objective on the stock.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same period last year, the business posted $2.11 EPS. UnitedHealth Group’s revenue for the quarter was up 9.5% on a year-over-year basis.
A number of other equities analysts have also recently commented on UNH. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein restated an “outperform” rating and set a $210.00 target price on shares of UnitedHealth Group in a report on Tuesday, October 10th. Jefferies Group raised their target price on UnitedHealth Group from $215.00 to $225.00 and gave the company a “buy” rating in a report on Friday, October 13th. Finally, BMO Capital Markets started coverage on UnitedHealth Group in a report on Monday, October 16th. They set an “outperform” rating and a $250.00 target price for the company. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $243.22.
Shares of UnitedHealth Group (NYSE UNH) traded up $1.65 during trading on Monday, reaching $245.21. The company had a trading volume of 3,266,346 shares, compared to its average volume of 3,100,000. UnitedHealth Group has a 12 month low of $156.49 and a 12 month high of $246.98. The stock has a market cap of $237,080.00, a PE ratio of 22.90, a price-to-earnings-growth ratio of 1.42 and a beta of 0.66. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in UNH. Marshall Wace LLP grew its stake in shares of UnitedHealth Group by 441.4% in the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock valued at $2,578,000 after purchasing an additional 11,361 shares during the last quarter. American Century Companies Inc. grew its stake in shares of UnitedHealth Group by 16.9% in the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after purchasing an additional 681,111 shares during the last quarter. Schwab Charles Investment Management Inc. grew its stake in shares of UnitedHealth Group by 5.3% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after purchasing an additional 183,401 shares during the last quarter. Essex Financial Services Inc. grew its stake in shares of UnitedHealth Group by 12.3% in the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock valued at $1,640,000 after purchasing an additional 967 shares during the last quarter. Finally, Bainco International Investors grew its stake in shares of UnitedHealth Group by 5.4% in the 3rd quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock valued at $16,192,000 after purchasing an additional 4,202 shares during the last quarter. 86.11% of the stock is currently owned by institutional investors.
In other UnitedHealth Group news, Director Michele J. Hooper sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the transaction, the director now owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. Insiders have sold a total of 33,853 shares of company stock worth $7,517,108 in the last three months. Corporate insiders own 0.89% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Inc to Post FY2019 Earnings of $13.38 Per Share, Oppenheimer Forecasts (UNH)” was published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.truebluetribune.com/2018/01/23/unitedhealth-group-inc-to-post-fy2019-earnings-of-13-38-per-share-oppenheimer-forecasts-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.